Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Systemic Sclerosis · Diffuse Sclerosis Systemic · Interstitial Lung Disease · Pulmonary Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Shawna McIntyre, RN) · mcintyresm@upmc.edu · 412-692-5552
Contact: Principal Investigator (Paul Szabolcs, MD)
Robyn Domsic, MD, MPH (Sub-investigator)
Annie Im, MD (Sub-investigator)
Daniel Kass, MD (Sub-investigator)
Geoffrey Kurland, MD (Sub-investigator)
Robert Lafyatis, MD (Sub-investigator)
Adam Olson, MD (Sub-investigator)
Kathryn Torok, MD (Sub-investigator)
Allison Morris, MD, MS (Sub-investigator)
Kirsten Rose-Felker, MD (Sub-investigator)
Franziska Rosser, MD, MPH (Sub-investigator)
Paulina Horvei, MD (Sub-investigator)
Joshua Levenson, MD (Sub-investigator)
Archana Ramgopal, DO (Sub-investigator)
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Robyn Domsic, MD, MPH) · domsicrt@upmc.edu · 412-383-8000
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Robert Lafyatis, MD) · lafyatisra@upmc.edu · 412-647-6700

Study leads

Paul Szabolcs, MD
Principal Investigator
University of Pittsburgh

View source on ClinicalTrials.gov Contact study team (email)